可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]董 力,刘兴会,石应康.心脏机械瓣膜置换术后妊娠妇女低强度华法林抗凝治疗56例[J].中华胸心血管外科杂志, 2011,27(1): 8-10.
[2]李 杰,刘国勋,凌光鑫,等.血浆D二聚体动态监测对知道换瓣术后抗凝治疗的临床意义[J].广东医学院学报,1996,14(2):103-104.
[3]Wesseling J,Van Driel D,Heymans HS,et al.Coumarins during pregnancy:long-term effects on growth and development of school-age children[J].Thromb Haemost,2001,85(4):609-613.
[4]葛蓓蕾,田陆云,王 红.华法林个体化用药的研究进展[J].中国老年学杂志,2012,32(10):2201-2204.
[5]喻杰峰,胡建国,周新民,等.心瓣膜置换术后孕产妇抗凝治疗(附183例临床报道)[J].中国现代医学杂志,2009(11):1713-1715.
[6]李 涛,赖 怡,边 策,等.机械心脏瓣膜置换术后孕早期肝素替代华法林抗凝治疗对妊娠结局影响的Meta分析[J].中国循证医学杂志,2008,8(1):42-46.
[7]Oran B,Lee-Parritz A,Ansell J.Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy[J].Thromb Haemost,2004,92(4):747-751.
[8]Van de Werf F,Brueckmann M,Connolly SJ,et al.A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement(RE-ALIGN)[J].Am Heart J,2012,163(6):931-937,e1.
[9]Kaeberich A,Reindl I,Raaz U,et al.Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro study[J].J Thromb Thrombolysis,2011,32(4):417-425.
[10]田国祥,魏万林,张 灵,等.后华法林时代口服抗凝新秀:达比加群、利伐沙班、阿哌沙班[J].中国循证心血管医学,2011,03(5):403-406.